Merck Mercuriadis faces the future… and stares down his critics

A report from investment manager Stifel – since blasted as “naive” by Mercuriadis – last month questioned the way in which the value of Hipgnosis’ acquired assets are written up after periodic NAV (Net Asset Value) re-assessments from independent valuer Massarsky. Meanwhile, possibly briefed by Hipgnosis competitors, some of the business pages of the UK’s media are becoming increasingly hostile.

Source: Merck Mercuriadis faces the future… and stares down his critics

Get the latest RightsTech news and analysis delivered directly in your inbox every week
We respect your privacy.